Here's Wouldn't Touch Tilray: A Cautious Investor Guide
Tilray’s pivot to CBD and alcohol sparks questions about profitability and risk. This guide cuts through the hype, of...
Explore withdrawal approaches for portfolios with SP 500 and Total Stock Market funds to sustain income and minimize risk.
28,406 articlesTilray’s pivot to CBD and alcohol sparks questions about profitability and risk. This guide cuts through the hype, of...
Three forces—higher mortgage rates, tighter consumer budgets, and rising build costs—are shaping housing stocks under...
Ackman's bold pivot away from Alphabet toward AI bets has investors talking. This guide breaks down what happened, wh...
As biotech investors digest Recursion's latest quarterly results, this Deep Dive breaks down what recursion (rxrx) 20...
A summer social security payment change will impact 3.6 million Direct Express users. This guide explains what’s chan...
March brings continued AI momentum, and two heavyweight names lead the charge: Nvidia and TSM. This article compares ...
When margins rebound in the energy sector, even senior executives may trim holdings to align with evolving risk and o...
A high-profile creator faced a dramatic revenue tumble after backlash, underscoring how follower counts don’t guarant...
Two pharma giants sit at the center of the booming weight-loss drug market. This piece breaks down which could offer ...
Europe's quest for cheaper inputs produced resilience gaps. Leaders now pivot to redundancy and security, risking hig...
Retirees who keep working while collecting Social Security can face temporary benefit withholdings, but the money isn...
Legendary investor Paul Tudor Jones warns that the Trump-era market boom could end in a 30-35% correction, even as he...